The Centers for Medicare & Medicaid Services today updated the Parts B and D drug spending dashboards with 2016 information. The dashboards provide pricing and utilization information for drugs covered under Medicare Parts B and D, including the total amount the program spent on a covered drug, how many beneficiaries used the drug, the cost per unit and the change in price from the prior year. Today’s update adds new fields, including the Average Sales Price, the number of manufacturers producing the drug, and what the drug is used to treat. This information is now available for all covered Part B and D drugs. The 2016 data show double-digit increases in spending per unit (i.e., price) for 876 Part D drugs and 145 Part B drugs, with 31 drugs increasing by more than 100%. CMS also released updated data on the prescription drugs prescribed by individual physicians and other providers paid under Medicare Part D.

Headline
The Hospital Insurance Trust Fund has been projected to become insolvent in 2033, according to the Medicare Board of Trustees’ annual report released June 9.…
Headline
Members of Congress and hospital and health system leaders today gathered for a briefing in Washington, D.C., to discuss how payment delays in Medicare…
Headline
Eli Lilly said June 1 it will deny 340B Drug Pricing Program discounts to providers that do not meet its documentation requirements by next week.In a statement…
Headline
The Centers for Medicare & Medicaid Services June 1 issued an interim final rule with comment period implementing the statutory requirement that certain…
Headline
The Centers for Medicare & Medicaid Services May 28 issued a final rule making changes to the Increasing Organ Transplant Access Model beginning July 1.…
Headline
The Centers for Medicare & Medicaid Services May 20 released a proposed rule that would modify policies governing Medicaid state-directed…